The sustained inhibitory effects of PTD on key inflammatory markers (NO, TNF-α, and IL-6) underscore its therapeutic potential in managing chronic inflammatory conditions like rheumatoid arthritis. This evidence concerns the gene IL6 and rheumatoid arthritis.